APA (7th ed.) Citation

Ye, Y., Gaudy, A., Thomas, M., Reyes, J., Burkhardt, B., Horan, G., . . . Palmisano, M. (2022). Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants. Clinical Pharmacology in Drug Development, 11(12), 1394. https://doi.org/10.1002/cpdd.1178

Chicago Style (17th ed.) Citation

Ye, Ying, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a C‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants." Clinical Pharmacology in Drug Development 11, no. 12 (2022): 1394. https://doi.org/10.1002/cpdd.1178.

MLA (9th ed.) Citation

Ye, Ying, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a C‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants." Clinical Pharmacology in Drug Development, vol. 11, no. 12, 2022, p. 1394, https://doi.org/10.1002/cpdd.1178.